RS3-Novelose 330 decreased food intake and body weight, low-density lipoprotein cholesterol and serum total cholesterol, promoted the growth of the main butyrate producing bacteria in Lachnospiraceae , Roseburia and Bifidobacterium , which indicated that the positive effects of RS3 in regulating serum lipids is associated with the intestinal microflora and production of short chain fatty acids (Chen et al
Without insurance, the drugs can cost $1,000 or more a month
The STEP 2 trial in adults with type 2 diabetes (N=1,210) reported a vomiting rate of 21.2% vs
FDA-approved drugs in each class GLP-1 receptor agonist medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound also a GIP agonist), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
J Ethnopharmacol 127:3237